Arkolith/Insider Trading/VIVO/Form 4

Kenny John P.

Chief Executive Officer, DirectorMERIDIAN BIOSCIENCE INC (VIVO) · full profile →Form 4 · filed Jun 28, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.3M
Net Open-Market Flow
-$2.3M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 27, 2022Option exercise(M)61K$10.10$621K327K
Jun 27, 2022Sell(S)61K$30.39$1.9M265K
Jun 24, 2022Option exercise(M)14K$10.10$137K279K
Jun 24, 2022Sell(S)14K$30.00$407K265K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 27, 2022Option exercise(M)61K—$066K
Jun 24, 2022Option exercise(M)14K—$0127K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001127602-22-018184) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML